Oruka Therapeutics ORKA
NASDAQ ORKA
$84.52 +1.10 (+1.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Oruka Therapeutics (ORKA) Amortization of Deferred Charges (2014 - 2015)

Updated

Oruka Therapeutics (ORKA) reported Amortization of Deferred Charges of $56,000 for Q4 2015, up 69.7% from $33,000 a year earlier and up 1.8% from the prior quarter.

Analysis

Oruka Therapeutics (ORKA) Amortization of Deferred Charges (2014 - 2015) Analysis & Trends

For FY2015, Oruka Therapeutics posted Amortization of Deferred Charges of $189,000, up 182.1% from FY2014.

  • By year, Amortization of Deferred Charges came in at $67,000 in FY2014.
  • Per Business Quant data, the three quarters before Q4 2015 came in at $55,000 (Q3 2015), $47,000 (Q2 2015) and $31,000 (Q1 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Oruka Therapeutics 5.31 Bn 3.37 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 56,000.00
Sep 30, 2015 55,000.00
Jun 30, 2015 47,000.00
Mar 31, 2015 31,000.00
Dec 31, 2014 33,000.00
API Access

Oruka Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ORKA&period=max&api_key=YOUR_API_KEY